SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LT who wrote (1339)6/18/1998 10:33:00 PM
From: Andrew H  Read Replies (1) of 5402
 
LT, is is true that funds will not generally invest in OTCBB stocks and some are prohibited by their by laws from doing so. However, as with anything human, there are, of course exceptions. Furthermore the term being used here is "institutional buying," which covers a lot more than mutual funds--banks, investment groups, retirement funds, etc., etc.

Certainly you wouldn't find a Fidelity fund taking a position in SGNC, but some more speculative groups might possibly be interested. And with the small market cap and relatively small float, even a little institutional buying could make a difference. There is a great need for a viable blood substitute and there has not been great luck in producing one. The winner(s) will make a fortune. But the odds are long.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News